BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 12568631)

  • 1. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
    Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the management of oral ulcers in Behçet's disease.
    Taylor J; Glenny AM; Walsh T; Brocklehurst P; Riley P; Gorodkin R; Pemberton MN
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD011018. PubMed ID: 25254615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.
    Watanabe T; Takeuchi T; Handa O; Sakata Y; Tanigawa T; Shiba M; Naito Y; Higuchi K; Fujimoto K; Yoshikawa T; Arakawa T
    PLoS One; 2015; 10(4):e0122330. PubMed ID: 25874951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
    Arabaci T; Kara C; Ciçek Y
    J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
    Talley NJ; Riff DS; Schwartz H; Marcuard SP
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1603-11. PubMed ID: 11564000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
    Lee JH; Jung JY; Bang D
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rebamipide and levamisole in the treatment of patients with recurrent aphthous ulcer - a comparative study.
    M K PD; D N S V R; Koppal S; Byatnal AR; Rukmangada T; Byatnal AA
    J Clin Diagn Res; 2014 Nov; 8(11):ZC119-22. PubMed ID: 25584301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan.
    Miwa H; Osada T; Nagahara A; Ohkusa T; Hojo M; Tomita T; Hori K; Matsumoto T; Sato N
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1826-31. PubMed ID: 17074021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of aphthosis with thalidomide and with colchicine].
    Genvo MF; Faure M; Thivolet J
    Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy.
    Femiano F; Buonaiuto C; Gombos F; Lanza A; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):402-7. PubMed ID: 19926502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.
    Chams-Davatchi C; Barikbin B; Shahram F; Nadji A; Moghaddassi M; Yousefi M; Davatchi F
    Int J Rheum Dis; 2010 Aug; 13(3):253-8. PubMed ID: 20704623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
    Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
    J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.
    Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H
    J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
    Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide for treatment of recurrent oral aphthae in Adamantiades-Behçet's disease.
    Ossorio-García L; Jiménez-Gallo D; de la Varga-Martínez R; Linares-Barrios M
    J Dtsch Dermatol Ges; 2018 Aug; 16(8):1029-1031. PubMed ID: 29998511
    [No Abstract]   [Full Text] [Related]  

  • 19. Complex aphthosis and Behçet's disease.
    McCarty MA; Garton RA; Jorizzo JL
    Dermatol Clin; 2003 Jan; 21(1):41-8, vi. PubMed ID: 12622267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.